The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
COVID-19 and comorbidities: Deleterious impact on infected patients
Open accessAbstract
The pandemic situation with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus disease 2019 (COVID-19) is presented with asymptomatic, mild, or severe pneumonia-like symptoms. COVID-19 patients with diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular diseases (CVD), hypertension, malignancies, HIV, and other comorbidities could develop a life-threatening situation. SARS-CoV-2 utilizes ACE-2 receptors found at the surface of the host cells to get inside the cell. Certain comorbidities are associated with a strong ACE-2 receptor expression and higher release of proprotein convertase that enhances the viral entry into the host cells. The comorbidities lead to the COVID-19 patient into a vicious infectious circle of life and are substantially associated with significant morbidity and mortality. The comorbid individuals must adopt the vigilant preventive measure and require scrupulous management. In this review, we rigorously focused on the impact of common morbidities in COVID-19 patients and recapitulated the management strategies with recent directions. We found limited resources describing the association of comorbidities in COVID-19; however, our review delineates the broader spectrum of comorbidities with COVID-19 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 1×
“establishment of severe symptoms among COVID-19 individuals, including structural damage to lungs, weak immunity and hyper mucous production [20].”
BackgroundYang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259 · cited 1×
“Different countries have a variable proportion of patients admitted to ICU as China reported 7-26%, 5-12% in Italy, and the highest rate recorded in the United States, 81% [46-47].”
BackgroundSimonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Jin, X., Lian, J.-S., Hu, J.-H., Gao, J., Zheng, L., Zhang, Y.-M., Hao, S.-R., Jia, H.-Y., Cai, H., Zhang, X.-L., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320926 · Cited by 1,385
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
COVID-19 and Multiorgan Response
Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100618 · Cited by 1,022
Coronavirus disease 2019 (COVID-19) in Italy
Livingston, E., & Bucher, K. (2020) · JAMA · doi:10.1001/jama.2020.4344 · Cited by 1,010
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., Deng, Y., & Lin, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25889 · Cited by 724
Badawi, A., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Comorbidities and multi-organ injuries in the treatment of COVID-19
Wang, T., Du, Z., Zhu, F., Cao, Z., An, Y., Gao, Y., & Jiang, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30558-4 · Cited by 632
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Bonow, R. O., Fonarow, G. C., O’Gara, P. T., & Yancy, C. W. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1105 · Cited by 594
Caution on Kidney Dysfunctions of COVID-19 Patients
Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., Song, S., Li, J., Duan, G., Zhou, Y., Wu, X., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3559601 · Cited by 522
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., et al. (2020) · Allergy · doi:10.1111/all.14309 · Cited by 502
Clinical management of COVID-19
Varghese, G. M., John, R., Manesh, A., Karthik, R., & Abraham, O. C. (2020) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_957_20 · Cited by 467
Patel, A., Jernigan, D. B., 2019-nCoV CDC Response Team, 2019-nCoV CDC Response Team, Abdirizak, F., Abedi, G., Aggarwal, S., Albina, D., Allen, E., Andersen, L., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6905e1 · Cited by 449
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
Martinez, M. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-20 · Cited by 444
China cardiovascular diseases report 2018: an updated summary.
Ma, L., Chen, W., Gao, R.-L., Liu, L., Zhu, M., Wang, Y., Wu, Z., Li, H., Gu, D., Yang, Y., et al. (2020) · PubMed · doi:10.11909/j.issn.1671-5411.2020.01.001 · Cited by 399
Chan, J. W. M. (2003) · Thorax · doi:10.1136/thorax.58.8.686 · Cited by 394
Kulcsar, K. A., Coleman, C. M., Beck, S. E., & Frieman, M. B. (2019) · JCI Insight · doi:10.1172/jci.insight.131774 · Cited by 373
Schiffrin, E. L., Flack, J. M., Ito, S., Muntner, P., & Webb, R. C. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa057 · Cited by 372
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y., Lu, X., Zhang, J., Du, H., Yan, Y., Akdis, C. A., & Gao, Y. (2020) · Allergy · doi:10.1111/all.14289 · Cited by 347
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
Sun, J., Zhu, A., Li, H., Zheng, K., Zhuang, Z., Chen, Z., Shi, Y., Zhang, Z., Chen, S.-B., Liu, X., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1760144 · Cited by 344
Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics
Maddaloni, E., & Buzzetti, R. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3321 · Cited by 305
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients
Pene, F., Merlat, A., Vabret, A., Rozenberg, F., Buzyn, A., Dreyfus, F., Cariou, A., Freymuth, F., & Lebon, P. (2003) · Clinical Infectious Diseases · doi:10.1086/377612 · Cited by 303
Rao, S., Lau, A., & So, H.-C. (2020) · Diabetes Care · doi:10.2337/dc20-0643 · Cited by 268
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
Fernandez, C., Rysä, J., Almgren, P., Nilsson, J., Engström, G., Orho‐Melander, M., Ruskoaho, H., & Melander, O. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12783 · Cited by 211
COVID 19 and the Patient with Obesity – The Editors Speak Out
Ryan, D. H., Ravussin, E., & Heymsfield, S. (2020) · Obesity · doi:10.1002/oby.22808 · Cited by 207
Patel, A., & Jernigan, D. B. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15805 · Cited by 197
Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019
Liu, Y., Sun, W., Li, J., Chen, L., Wang, Y., Zhang, L., & Yu, L. (2020) · medRxiv · doi:10.1101/2020.02.17.20024166 · Cited by 172
Intensive care during the coronavirus epidemic
China Critical Care Clinical Trials Group (CCCCTG), Qiu, H., Tong, Z., Ma, P., Hu, M., Peng, Z., Wu, W., & Du, B. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05966-y · Cited by 164
Chen, Y.-T., Shao, S., Lai, E. C., Hung, M., & Chen, Y.-C. (2020) · Critical Care · doi:10.1186/s13054-020-03134-8 · Cited by 52
Cited by
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Dougan, M., Nirula, A., Azizad, M., Mocherla, B., Gottlieb, R. L., Chen, P., Hebert, C., Perry, R., Boscia, J., Heller, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102685 · Cited by 663
Lai, A., Chang, M. L., O'Donnell, R. P., Zhou, C., Sumner, J. A., & Hsiai, T. K. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146464 · Cited by 25
Metadata
- Authors
- Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S.
- Venue
- Journal of Infection and Public Health
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 13
- Issue
- 12
- Pages
- 1833-1839
- ISSN
- 1876-0341 (ISSN-L)
- OpenAlex
- W3046256437
- Cited by
- 996
- References
- 54
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.